Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors

<em><strong>Objective(s):</strong></em> Allylbenzenes have been recently developed as inhibitors of lipoxygenases. They decrease peroxidation activity via mimicking 1,4-unsaturated bonds of fatty acids by their allyl portion. We designed and synthesized new derivatives of all...

Full description

Bibliographic Details
Main Authors: Mina Mousavian, Seyed Jamal Alavi, Raheleh Rahbarian, Majid Rajabian, Hossein Orafai, Hamid Sadeghian
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2020-08-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
15
Online Access:http://ijbms.mums.ac.ir/article_15830_0057a23afac8a307ccd50aa659f3a6a4.pdf
id doaj-01d8868b679846d2831fdbbe3f923007
record_format Article
spelling doaj-01d8868b679846d2831fdbbe3f9230072020-11-25T02:17:23ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences 2008-38662008-38742020-08-0123898498910.22038/ijbms.2020.36793.876315830Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitorsMina Mousavian0Seyed Jamal Alavi1Raheleh Rahbarian2Majid Rajabian3Hossein Orafai4Hamid Sadeghian5Department of Biology, Faculty of Science, Payame Noor University, Mashhad, IranDepartment of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Biology, Faculty of Science, Payame Noor University, Mashhad, IranDepartment of Biology, Faculty of Science, Payame Noor university, Tehran, IranDepartment of Pharmaceutics, Faculty of Pharmacy, University of Al-Zahraa for Women, Karbala, IraqDepartment of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran|Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran<em><strong>Objective(s):</strong></em> Allylbenzenes have been recently developed as inhibitors of lipoxygenases. They decrease peroxidation activity via mimicking 1,4-unsaturated bonds of fatty acids by their allyl portion. We designed and synthesized new derivatives of allyl benzenes (6a-f) with isopropoxy and amide substituents at ortho and meta positions towards allyl group, respectively. The inhibitory potency of the synthetized allylbenzenes against soybean 15-lipoxygenase (SLO) and subsequently structure-activity relationships was assessed.<br /><em><strong>Materials and Methods:</strong></em> 3-allyl-4-isopropoxybenzenamine (5) as starting material was synthesized by coupling of 4-nitropheol with allyl bromide, performing Claisen rearrangement and finally reduction of the nitro moiety. Final products 6a-f were prepared via amidation of 5 with the desired acyl chloride.<br /><em><strong>Results:</strong></em> Among the compounds, N-(3-allyl-4-isopropoxyphenyl)adamantan carboxamide (6f) potentially showed best inhibition (IC50 = 1.35 µM) while 6a with cyclopropyl carboxamide moiety was the weakest inhibitor and 6e with phenyl carboxamide moiety showed no effect. Energy minimized 3D structures of the compounds were docked into the active site pocket of SLO. For the aliphatic amides, docking results showed compatibility between inhibitory potency and average Ki of the cluster conformers, in which their allyl moiety oriented towards SLO iron core. For the aliphatic analogs, by enlargement of the amide moiety size the inhibitory potency was increased.<br /><em><strong>Conclusion:</strong></em> Docking results showed that orientation of the amide and allyl moieties of the inhibitors in the active site pocket is the major factor in inhibitory potency variation. Based on the mentioned orientation, for cycloaliphatic amides, by enlargement of the amide moiety both inhibition potency and calculated binding energy increases.http://ijbms.mums.ac.ir/article_15830_0057a23afac8a307ccd50aa659f3a6a4.pdf15lipoxygenase allylbenzene dmab kinetic mbth
collection DOAJ
language English
format Article
sources DOAJ
author Mina Mousavian
Seyed Jamal Alavi
Raheleh Rahbarian
Majid Rajabian
Hossein Orafai
Hamid Sadeghian
spellingShingle Mina Mousavian
Seyed Jamal Alavi
Raheleh Rahbarian
Majid Rajabian
Hossein Orafai
Hamid Sadeghian
Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors
Iranian Journal of Basic Medical Sciences
15
lipoxygenase allylbenzene dmab kinetic mbth
author_facet Mina Mousavian
Seyed Jamal Alavi
Raheleh Rahbarian
Majid Rajabian
Hossein Orafai
Hamid Sadeghian
author_sort Mina Mousavian
title Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors
title_short Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors
title_full Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors
title_fullStr Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors
title_full_unstemmed Design, synthesis, and SAR study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors
title_sort design, synthesis, and sar study of isopropoxy allylbenzene derivatives as 15-lipoxygenase inhibitors
publisher Mashhad University of Medical Sciences
series Iranian Journal of Basic Medical Sciences
issn 2008-3866
2008-3874
publishDate 2020-08-01
description <em><strong>Objective(s):</strong></em> Allylbenzenes have been recently developed as inhibitors of lipoxygenases. They decrease peroxidation activity via mimicking 1,4-unsaturated bonds of fatty acids by their allyl portion. We designed and synthesized new derivatives of allyl benzenes (6a-f) with isopropoxy and amide substituents at ortho and meta positions towards allyl group, respectively. The inhibitory potency of the synthetized allylbenzenes against soybean 15-lipoxygenase (SLO) and subsequently structure-activity relationships was assessed.<br /><em><strong>Materials and Methods:</strong></em> 3-allyl-4-isopropoxybenzenamine (5) as starting material was synthesized by coupling of 4-nitropheol with allyl bromide, performing Claisen rearrangement and finally reduction of the nitro moiety. Final products 6a-f were prepared via amidation of 5 with the desired acyl chloride.<br /><em><strong>Results:</strong></em> Among the compounds, N-(3-allyl-4-isopropoxyphenyl)adamantan carboxamide (6f) potentially showed best inhibition (IC50 = 1.35 µM) while 6a with cyclopropyl carboxamide moiety was the weakest inhibitor and 6e with phenyl carboxamide moiety showed no effect. Energy minimized 3D structures of the compounds were docked into the active site pocket of SLO. For the aliphatic amides, docking results showed compatibility between inhibitory potency and average Ki of the cluster conformers, in which their allyl moiety oriented towards SLO iron core. For the aliphatic analogs, by enlargement of the amide moiety size the inhibitory potency was increased.<br /><em><strong>Conclusion:</strong></em> Docking results showed that orientation of the amide and allyl moieties of the inhibitors in the active site pocket is the major factor in inhibitory potency variation. Based on the mentioned orientation, for cycloaliphatic amides, by enlargement of the amide moiety both inhibition potency and calculated binding energy increases.
topic 15
lipoxygenase allylbenzene dmab kinetic mbth
url http://ijbms.mums.ac.ir/article_15830_0057a23afac8a307ccd50aa659f3a6a4.pdf
work_keys_str_mv AT minamousavian designsynthesisandsarstudyofisopropoxyallylbenzenederivativesas15lipoxygenaseinhibitors
AT seyedjamalalavi designsynthesisandsarstudyofisopropoxyallylbenzenederivativesas15lipoxygenaseinhibitors
AT rahelehrahbarian designsynthesisandsarstudyofisopropoxyallylbenzenederivativesas15lipoxygenaseinhibitors
AT majidrajabian designsynthesisandsarstudyofisopropoxyallylbenzenederivativesas15lipoxygenaseinhibitors
AT hosseinorafai designsynthesisandsarstudyofisopropoxyallylbenzenederivativesas15lipoxygenaseinhibitors
AT hamidsadeghian designsynthesisandsarstudyofisopropoxyallylbenzenederivativesas15lipoxygenaseinhibitors
_version_ 1724886676944191488